Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Mgc Pharmaceuticals Limited (MXC.LN)

Mgc Pharmaceuticals Limited (MXC.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mgc Pharmaceuticals Limited 295 Rokeby Road Suite 1 Subiaco WA 6008 AUS

P: +61 865552950

Description:

Argent Biopharma Ltd is an innovative drug discovery company that addresses unmet medical needs by combining PolyPharmacology and Nanotechnology, aspiring to be a renowned global leader in the biopharmaceutical sector. Its products includes CannEpil for refractory epilepsy and cerebral palsy, CimetrA for acute lung injury and ARDS and CogniCann for enhancing the quality of life in dementia and Alzheimer's patients, with additional treatments in development.

Key Statistics

Overview:

Market Capitalization, $K 10,471
Shares Outstanding, K 43,852
Annual Sales, $ 3,388 K
Annual Net Income, $ -20,824 K
% of Institutional Shareholders 0.47%

Growth:

1-Year Return -96.00%
3-Year Return -99.41%
5-Year Return 0.00%
5-Year Revenue Growth 62.74%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -3.21
Dividend Payout Ratio 0.00%
Most Recent Split 1-1000 on 11/02/23

MXC.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % N/A
Return-on-Assets % -104.48%
Profit Margin % -614.71%
Debt/Equity N/A
Price/Sales 3.35
Price/Book 14.14
Book Value/Share 0.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar